注意力缺陷多动障碍 (ADHD) 治疗市场分析及预测(按规模、份额、增长和趋势)2030 年

  • Report Code : TIPRE00003833
  • Category : Pharmaceuticals
  • No. of Pages : 150
Buy Now

ADHD Therapeutics Market Size and Share|2030

Buy Now

【研究报告】2022年ADHD治疗市场规模为285.9455亿美元,预计到2030年将达到647.4237亿美元;预计 2022 年至 2030 年复合年增长率为 10.8%。
市场洞察和分析师观点:
注意力缺陷/多动障碍 (ADHD) 是一种复杂的神经发育障碍,影响个人集中注意力、控制冲动行为和管理多动的能力。它大多在儿童时期被诊断出来,但症状可能持续到青春期和成年期。 ADHD 的治疗通常涉及多学科方法,包括行为治疗、教育和兴奋剂和非兴奋剂等药物治疗。
ADHD 患病率不断上升以及治疗药物需求激增等因素推动了 ADHD 患者的增长。市场。然而,与 ADHD 药物相关的副作用及其有限的缓解阻碍了 ADHD 治疗市场的增长。
增长驱动因素和限制:
根据疾病控制和预防中心 (CDC) 于 2022 年 2 月发表的文章据统计,2016 年至 2019 年间,美国约有 600 万 3-17 岁儿童被诊断患有 ADHD,占总人口的 9.8%。此外,根据 PubMed Central 2022 年发表的一篇文章,ADHD 影响了 5-7.2% 的儿童。全球儿童和 2.5-6.7% 的成年人。根据最近的估计,美国青少年的频率要高得多,约为 8.7%,即 530 万。尽管传统上认为多动症是一种儿童疾病,但高达 90% 的多动症儿童在成年后仍会出现症状。一项研究表明,也有可能在成人中进行诊断,因为 75% 的 ADHD 患者之前在儿童时期并未被诊断出来。 ADHD 通常与焦虑、抑郁、学习障碍和药物滥用等共病有关。这些合并症的存在增加了治疗的复杂性,需要采取多维方法来解决多动症症状和相关病症。建议使用精神兴奋剂和非兴奋剂等药物,这些药物可以帮助儿童在日常生活中控制多动症症状,并有助于调节可能给他们生活的各个方面(包括个人生活和学业成绩)带来困难的行为。因此,上述因素正在增加对 ADHD 药物的需求,促进 ADHD 治疗药物市场份额的扩大。
然而,由于症状缓解有限,ADHD 治疗药物市场的增长受到限制。与使用治疗方法相关的影响。精神兴奋药物的常见副作用包括食欲下降、失眠、焦虑增加、易怒、胃痛和头痛。当药物的作用消失时,多动症症状可能会复发,从而导致更强烈的“反弹”效应。

报告细分和范围:
“多动症治疗市场分析”已通过考虑以下细分市场进行:药物类型、年龄组和分销渠道。
细分分析:
ADHD 治疗市场按药物类型分为兴奋剂和非兴奋剂药物。
兴奋剂药物细分市场在 2022 年占据较大的 ADHD 治疗市场份额,预计 2022 年至 2030 年期间复合年增长率将更高。
按药物类型划分的 ADHD 治疗市场 – 2022 年和 2030 年
根据年龄组,ADHD 治疗药物市场分为儿童、青少年和成人。儿科和青少年细分市场将在 2022 年占据更大的市场份额。成人细分市场预计 2022 年至 2030 年将实现更高的复合年增长率。
就分销渠道而言,ADHD 治疗市场分为医院药房、零售药房、和电子商务。 2022 年,医院药房领域占据最大的市场份额,预计 2022 年至 2030 年复合年增长率最高。
区域分析:
北美、欧洲、亚太地区、南美洲和中美洲以及中东东部和非洲是为得出 ADHD 治疗市场报告范围而分析的主要地区。
2022 年,北美占据全球最大市场份额。在北美,美国在 2022 年占据最大的市场份额,预计从 2022 年到 2030 年将继续占据主导地位。 ADHD 治疗市场的增长主要是由于美国 ADHD 的高患病率。根据 Cingulate 的数据,到 2022 年,约 640 万 4 岁至 17 岁的儿童和青少年被诊断患有 ADHD。其中,超过 80% 的人接受了治疗,约 65% 的人在成年后仍持续出现 ADHD 症状。此外,患者负担能力的提高、有利的报销政策以及对现有药物认识的提高预计将推动市场增长。
由于该地区主要参与者的存在和多项战略举措,亚太地区是 ADHD 增长最快的市场致力于新产品的开发和营销。例如,2020 年 6 月,大冢制药有限公司和大冢制药开发与商业化有限公司报告了两项为期六周的 3 期临床试验的积极结果,该试验评估了口服 Centanafadine 的有效性、安全性和耐受性。 Centanafadine 是一种新的实验药物,旨在治疗诊断为 ADHD 的成年患者。该公司还计划研究 Centanafadine 对 ADHD 儿童的影响,并与美国食品和药物管理局讨论后续步骤。
行业发展和未来机遇:
ADHD 治疗市场预测可以帮助利益相关者市场规划他们的增长战略。市场主要参与者采取的举措如下:
2023 年 9 月,Cingulate Inc. 公布了其主要候选药物 CTx-1301(右哌甲酯)治疗 ADHD 的成人疗效和安全性 3 期研究结果。该公司利用其专利药物输送平台技术 Precision Timed Release (PTR) 来构建和推进下一代医药产品的管道。结果于 9 月 8 日在田纳西州纳什维尔举行的第 36 届年度心理学大会上公布。 2022 年 3 月,久光制药株式会社的全资子公司 Noven Pharmaceuticals, Inc. 获得美国食品和药物管理局的批准(FDA) 因其 XELSTRYM(右旋苯丙胺)透皮系统 CII,用于治疗成人和 6 岁及以上儿童患者的 ADHD。 2021 年 7 月,Corium, Inc. 推出了 AZSTARYS。这种创新药物结合了哌醋甲酯 (SDX) 和哌醋甲酯 (d-MPH),在美国用于 6 岁及以上患者的对症治疗。 AZSTARYS 于 2021 年 3 月获得 FDA 批准。它由两种药物的组合组成:70% d-MPH SDX 缓释前药(附表 IV)和 30% 速释 d-MPH(附表 II)。2021 年 4 月, Supernus Pharmaceuticals, Inc. 宣布美国 FDA 已批准 Qelbree(维洛嗪缓释胶囊)用于治疗 6-17 岁患者 ADHD。 竞争格局和主要公司:
Amneal Pharmaceuticals, Inc.;诺华公司;辉瑞公司;礼来公司;诺文制药公司;杨森制药公司;强生服务公司;真皮公司; Adlon 治疗公司;和 Teva Pharmaceutical Industries Ltd. 是 ADHD 治疗市场报告中介绍的主要参与者之一。这些公司采用产品开发策略来满足不断增长的客户需求,这使他们能够维持自己的品牌。
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What was the estimated size of the ADHD Therapeutics market in 2022?

The digital health market was valued at US$ 28,594.55 billion in 2022.

Which drug type segment dominates the ADHD Therapeutics market?

The ADHD Therapeutics market, by drug type, is segmented into stimulants and non-stimulant drugs. The stimulant drug segment held a larger market share in 2022, and the same segment is anticipated to register a higher CAGR during 2022-2030.

Which end-user segment dominates the ADHD Therapeutics market?

The ADHD Therapeutics market, by end-user, is segmented into hospitals and clinics, providers, payers, and others. In 2022, the hospitals and clinics segment held the largest market share, and the same segment is anticipated to register the highest CAGR during 2022–2030.

What is ADHD?

Attention deficit/hyperactivity disorder (ADHD) is a complex neurodevelopment disorder that affects individuals’ ability to focus, control impulsive behaviors, and manage hyperactivity. It is mostly diagnosed in childhood, but symptoms can persist into adolescence and adulthood. Treatment for ADHD often involves a multidisciplinary approach, including behavioral therapy, education, and medication such as stimulants and non-stimulants.

Who are the major players in the ADHD Therapeutics market?

The digital health market majorly consists of the players, including Amneal Pharmaceuticals, Inc.; Novartis AG; Pfizer, Inc.; Eli Lilly and Company; Noven Pharmaceuticals, Inc.; Janssen Pharmaceuticals, Inc.; Johnson & Johnson Services, Inc.; Corium Inc; Adlon Therapeutics LP; and Teva Pharmaceutical Industries Ltd. are among the key players profiled in the ADHD therapeutics market.

What factors drive the ADHD Therapeutics market?

Key factors driving the increasing prevalence of ADHD, combined with the increased demand for drugs for treatment, is propelling the market.

The List of Companies - ADHD Therapeutics Market

  1. Amneal Pharmaceuticals, Inc
  2. Novartis AG
  3. Pfizer, Inc.
  4. Eli Lilly And Company
  5. Noven Pharmaceuticals, Inc.
  6. Janssen Pharmaceuticals, Inc
  7. Johnson & Johnson Services, Inc.
  8. Corium Inc
  9. Adlon Therapeutics L.P
  10. Teva Pharmaceutical Industries Ltd

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Pharmaceuticals : READ MORE..